Tonucci Paolo 4
4 · Marex Group plc · Filed Jun 16, 2026
Research Summary
AI-generated summary of this filing
Marex Group (MRX) Chief Strategist Paolo Tonucci Sells Shares
What Happened
- Paolo Tonucci, Chief Strategist and CEO, Capital Markets at Marex Group plc, sold a total of 16,666 ordinary shares in open-market transactions on June 15, 2026 for aggregate proceeds of $1,040,850. The sales were reported in three lots: 1,658 shares at $61.74 ($102,367), 14,199 shares at $62.51 ($887,516), and 809 shares at $63.00 ($50,967). This was a sale (disposition), not a purchase or option exercise.
Key Details
- Transaction date: June 15, 2026; Form 4 filed June 16, 2026 (timely).
- Reported proceeds: $1,040,850 total.
- Price details / ranges:
- 1,658 shares: weighted avg $61.74; transactions ranged $60.945–$61.94 (F2).
- 14,199 shares: weighted avg $62.51; transactions ranged $61.965–$62.94 (F3).
- 809 shares: $63.00; transactions ranged $62.945–$63.075 (F4).
- Sale executed pursuant to a prearranged Rule 10b5-1 plan established October 22, 2025 (F1).
- Holdings note: the filing references 220,746 shares underlying deferred bonus awards included in reported holdings (F5). The exact number of shares owned after these sales is not specified in the excerpt — see the full Form 4 for the post-transaction total.
- Filing status: appears timely (no late-filing flag reported).
Context
- The 10b5-1 plan indicates these sales were made under a prearranged schedule, which typically means they were planned in advance rather than reactive to material nonpublic information. Sales by executives are common and can reflect routine portfolio management or tax/liquidity needs; they do not necessarily signal a change in company outlook. For complete context, check the full Form 4 and the company's recent disclosures.
Insider Transaction Report
Form 4
Tonucci Paolo
See Remarks
Transactions
- Sale
Ordinary Shares
[F1][F2]2026-06-15$61.74/sh−1,658$102,367→ 1,313,951 total - Sale
Ordinary Shares
[F1][F3]2026-06-15$62.51/sh−14,199$887,516→ 1,299,752 total - Sale
Ordinary Shares
[F1][F4][F5]2026-06-15$63.00/sh−809$50,967→ 1,298,943 total
Footnotes (5)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $60.945 to $61.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $61.965 to $62.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $62.945 to $63.075, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The number of ordinary shares reported herein includes 220,746 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Signature
/s/ Scott Linsley as Attorney-in-Fact, for Paolo Tonucci|2026-06-16